Optum said Thursday it acquired all shares of Catamaran at $61.50 per share in a cash transaction.
The combined companies will operate as OptumRx and utilize data analytics and other tools to facilitate synchronized and collaborative care management,  Optum added.
“OptumRx’s longtime business relationship and shared technology with Catamaran greatly simplifies the integration now underway, ” said Mark Thierer, former chairman and CEO of Catamaran and current CEO of the integrated OptumRx.